AzTrials
AzTrials

Mental Health IssueNCT04175561

A Dose of Nature: An Interdisciplinary Study of Green Prescriptions

A study testing Green prescription in people with Mental Health Issue and Depression, run by University of Sheffield.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The idea that spending time in natural environments can enhance one's health has been researched for several years. However, the concept of green prescribing--or prescribing a systematic nature-based intervention that can be monitored over time--has only recently generated traction in practice (although the principles… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Mental Health Issue, Depression
What is being tested?
Green prescription
Could I receive a placebo?
No, everyone receives an active treatment
How many people
240 participants
Where
No sites listed yet
Study dates
Mar 2020to Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Only adults - over 18 years of age with mild-moderate depression.
  • Patients will be residents of North Sheffield and part of the Network North Primary Care Network (PCN).
  • Patients will preferably be comfortable with outdoors and social settings.

Who cannot join

  • Those who are not adults - over 18 years of age with mild-moderate depression.
  • Patients who are not residents of North Sheffield and part of the Network North Primary Care Network (PCN).
  • Patients who are not comfortable with outdoors and social settings.

About this study

Official title: A Dose of Nature: An Interdisciplinary Study of Green Prescriptions and the Environment-Microbiome-Health Axis

The idea that spending time in natural environments can enhance one's health has been researched for several years. However, the concept of green prescribing--or prescribing a systematic nature-based intervention that can be monitored over time--has only recently generated traction in practice (although the principles can be traced back to several hundred years ago).

Green prescriptions (social prescribing with nature) could potentially help to reduce the costs of mainstream healthcare and could have important 'co-benefits', for example, by simultaneously enhancing the environment.

Read more

There are still a number of critical questions that need answering, such as what works best for whom, where and when, and a number of key constraints need to be addressed. The conceptual framework for this proposed trial has been informed by the results of a UK-wide green prescribing questionnaire (Stage 1 of PhD) and recommendations from the Improving Wellbeing through Urban Nature (IWUN) research project (www.iwun.uk).

The main (perceived) constraints to green prescribing acquired from the questionnaire include:

  • A lack of funding for all stakeholders
  • The research project aims to be cost-effective and not strictly reliant on other organisations
  • A lack of knowledge of how to start a green prescribing service
  • The project aims to demonstrate how to start a green prescribing service
  • A lack of opportunities and awareness of service availability
  • As above
  • Patient motivation and ease of access/travel etc.
  • The novel situational aspect of the project (within the premises of GP practices) aims to maximise access/minimise travel for patients
  • A lack of knowledge of the evidence and mechanisms
  • The research project aims to collect evidence on mental health, wellbeing and nature connectedness via an RCT-style experimental design
  • Referral and set-up time
  • As per funding objective - see top. The research project will also evaluate patient appointments/attendances (number and frequency) via the RCT approach

The researcher is proposing to conduct a 3-6 month randomised controlled trial (RCT) interventional study involving adult patients with mild-moderate depression as determined using the well-established PHQ-9 questionnaire. A key aim is to sustain this green prescribing service once the research is complete and to hopefully stimulate other trials across Sheffield and the UK (providing opportunities for important meta-analyses).

The intervention will include pocket gardening (activities in small, semi-permanent, versatile gardens) and nature-based activities hosted in the premises of GP surgeries in Sheffield's Network North region.

Read the detailed description

A green prescription is a prescribed nature-based health intervention designed for individuals with a defined need (or to complement orthodox medical treatments). Common examples of green prescribing activities include: therapeutic horticulture, biodiversity conservation volunteering, care farming, wild crafts and nature walks. Green prescriptions are typically provided for a set length of time (e.g. 12 weeks) but can be open ended.

As a green prescribing activity, therapeutic horticulture has several potential benefits including physical and mental health improvements, facilitating social co-mingling, educational and reward-based e.g. harvesting natural produce. It has already proven successful as a green prescribing activity in projects such as SAGE Greenfingers (sagesheffield.org.uk), which was established following a community needs assessment commissioned by Pitsmoor surgery in Sheffield.

This kind of green prescription provides natural environmental features, social context and meaningful activities - three important interacting phenomena in nature-based interventions. By integrating other nature-based activities such as simply noticing the local wildlife, this project also aims to open pathways (via senses, compassion, emotion meaning and beauty) to nature connectedness - one's emotional relationship with the natural world. The novel situational element of this project (i.e. hosted in GP surgery premises) aims to maximise accessibility and minimise travel for the patients, and to minimise multi-stakeholder logistics.

Furthermore, several policy statements--informed by empirical evidence--were recently published by the IWUN research project (www.iwun.uk). Amongst many other recommendations, these call for GP practices to enhance the biodiversity in their premises.

Importantly, the question of how GP practices can provide their own greenspaces to improve the mental health of their patients is also raised.

Re-designing the outdoor spaces surrounding GP practices and/or integrating new nature-based features and activities within these spaces could help to enhance patient (and staff) wellbeing. Creating pocket gardens (small multifunctional gardens typically installed in the pockets of empty urban spaces) and biodiverse spaces for green prescribing activities is one potential route, and an evaluation of this concept forms the basis of the research project.

There is also a severe lack of randomised controlled trial experiments in green prescribing research - further strengthening the rationale for the chosen experimental approach.

Being tested
Green prescription
Keywords
Green prescription, Nature-based health intervention, Nature on prescription, Mental health, Nature connectedness, Nature relatedness, Therapeutic horticulture
Medical subject headings
Depression, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Green prescriptionOther

    Green prescription intervention will include horticultural activities such as planting, harvesting, learning about ecology and sustainable food growing.

Study groups in NCT04175561
Study groupRoleWhat they receive
InterventionExperimentalParticipants in the intervention arm will be given a green prescription (gardening activities).
Receives: Other: Green prescription
ControlNo interventionParticipants in the control arm will not be given the intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Health Questionnaire-9 (PHQ-9) scale questionnaire assessing change in symptoms of depression

    Results of Patient Health Questionnaire-9 scale questionnaire (determining level of depression) will be the primary outcome measure. The PHQ-9 severity cut-off for this study will be as follows:

    • Mild = 5-9
    • Moderate = 10-14 (where a lower score indicates lower level of depression to a minimum score of 5 and a maximum score of 14 for higher levels of depression)

    Measured: Baseline (start of study), during (at 6 weeks), and post intervention (at 3 months)

Secondary outcomes (3)
  1. Nature Connectedness Index questionnaire assessing change in level of nature connectedness

    Results from the Nature Connectedness Index questionnaire to determine level of nature connectedness. This instrument comprises 6 questions and a 7-point response scale from "completely agree" to "completely disagree" (where 0 is lowest score of nature connectedness and 42 is the maximum score).

    Measured: Baseline (start of study), during (at 6 weeks), and post intervention (at 3 months)

  2. Perceived Stress Scale (PSS) questionnaire assessing change in symptoms of stress

    Results from the Perceived Stress Scale questionnaire. This is a 10-point measure using a 0-4 Likert style response system.

    Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress. Scores ranging from 0-13 would be considered low stress.

    Measured: Baseline (start of study), during (at 6 weeks), and post intervention (at 3 months)

  3. Warwick and Edinburgh Mental Wellbeing Scale (WEMWBS) assessing change in levels of wellbeing

    Results from the Warwick and Edinburgh Mental Wellbeing Scale. The Warwick and Edinburgh Mental Wellbeing Scale has 14 x statements and 5 x response categories, summed to provide a single score (where 14 is the lowest score of wellbeing and 70 is the maximum).

    Measured: Baseline (start of study), during (at 6 weeks), and post intervention (at 3 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Nov 2019
  2. Study startMar 2020 (estimated)
  3. Primary completionSep 2020 (estimated)
  4. Study completionDec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Social prescribing intervention based on RCT design
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
240 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04175561
Sponsor's protocol ID
IRAS 263091
Status last verified
Nov 2019
First submitted
18 Nov 2019
Last updated
25 Nov 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Green prescription in people with Mental Health Issue and Depression, run by University of Sheffield.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Health Questionnaire-9 (PHQ-9) scale questionnaire assessing change in symptoms of depression (time frame: Baseline (start of study), during (at 6 weeks), and post intervention (at 3 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in